TY - JOUR
T1 - Optimisation of rheumatic disease assessments in clinical trials, clinical care, and long-term databases
AU - Landewé, R. B. M.
AU - van der Heijde, D.
PY - 2014
Y1 - 2014
N2 - The assessment of disease in rheumatological diseases is rather complicated, because it may involve different contexts (clinical practice, clinical trials, observational studies, registries, etc.) as well as different domains (disease activity, physical function, radiographic damage, quality of life, etc.). Furthermore, available tools can be comprehensive but also rather condense, may be patient-oriented or rather physician-oriented, and so on. In this article all these levels that may matter in case of a choice of disease assessment tool are discussed, arriving at a conclusion that choosing the appropriate tool for the assessment of disease is not 'cookbook medicine'
AB - The assessment of disease in rheumatological diseases is rather complicated, because it may involve different contexts (clinical practice, clinical trials, observational studies, registries, etc.) as well as different domains (disease activity, physical function, radiographic damage, quality of life, etc.). Furthermore, available tools can be comprehensive but also rather condense, may be patient-oriented or rather physician-oriented, and so on. In this article all these levels that may matter in case of a choice of disease assessment tool are discussed, arriving at a conclusion that choosing the appropriate tool for the assessment of disease is not 'cookbook medicine'
M3 - Article
C2 - 25365081
SN - 0392-856X
VL - 32
SP - S-2-6
JO - Clinical and experimental rheumatology
JF - Clinical and experimental rheumatology
IS - 5 Suppl 85
ER -